☆ 4.8 Article

COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study

FRONTIERS IN IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Rheumatology

Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study

Satveer K. Mahil et al.

Summary: The study found that patients receiving methotrexate and targeted biological therapy had similar neutralizing antibody responses after the second vaccine dose, but lower T-cell responses. The longevity of vaccine-induced antibody responses in this population is currently unknown.

LANCET RHEUMATOLOGY (2022)

Add to Collection

Editorial Material Rheumatology

Immunity after COVID-19 vaccinations in immunocompromised patients with psoriasis

Laura Boekel

LANCET RHEUMATOLOGY (2022)

Add to Collection

Article Dermatology

Seroconversion after anti-SARS-CoV-2 mRNA vaccinations among moderate-to-severe psoriatic patients receiving systemic biologicals-Prospective observational cohort study

Eva Anna Piros et al.

Summary: This study investigated the antibody formation and incidence of side effects after mRNA-based anti-SARS-CoV-2 vaccinations in psoriatic patients receiving different biologicals compared to healthy controls. The results showed no significant differences in antibody levels and side effect incidence between the psoriatic patients and healthy controls after vaccination.

DERMATOLOGIC THERAPY (2022)

Add to Collection

News Item Infectious Diseases

Research in brief

Sharmila Devi

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies

Timothee Bruel et al.

Summary: There are differences in neutralizing activity of therapeutic antibodies against the SARS-CoV-2 Omicron BA.1 and BA.2 sublineages, and immunocompromised individuals treated with antibodies show elevated antibody levels but reduced neutralization against Omicron. Breakthrough infections with the Omicron variant are observed in some immunocompromised individuals despite antibody treatment.

NATURE MEDICINE (2022)

Add to Collection

Letter Medicine, General & Internal

Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

Emi Takashita et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Review Medicine, General & Internal

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis

Ainsley Ryan Yan Bin Lee et al.

Summary: This systematic review and meta-analysis compared the efficacy of covid-19 vaccines between immunocompromised and immunocompetent individuals. The results showed that immunocompromised patients, especially organ transplant recipients, had significantly lower rates of seroconversion after covid-19 vaccination. A second dose of the vaccine consistently improved seroconversion in all patient groups, although the improvement was smaller for organ transplant recipients. Targeted interventions, including a third dose (booster) of the vaccine, should be performed for immunocompromised patients.

BMJ-BRITISH MEDICAL JOURNAL (2022)

Add to Collection

Letter Dermatology

Immune response to SARS-CoV-2 mRNA vaccine in patients with psoriasis treated with biologics

Maruska Marovt et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2022)

Add to Collection

Article Rheumatology

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study

David Simon et al.

Summary: People with immune-mediated inflammatory diseases have a lower and less durable response to SARS-CoV-2 vaccination and are at risk of losing humoral immune protection. Adjusted vaccination schedules with earlier booster doses or more frequent re-doses, or both, could better protect these individuals.

LANCET RHEUMATOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics

Dario Graceffa et al.

Summary: Although psoriasis itself does not lead to a poor prognosis for COVID-19, the immunomodulatory agents used for its treatment may make patients more vulnerable to complications from SARS-CoV-2 infection and may affect the effectiveness of vaccines.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

Sho Iketani et al.

Summary: The identification of the Omicron variant of SARS-CoV-2 in Botswana in November 2021 sparked concern due to the spike protein alterations that could potentially evade antibodies. Further studies showed that the Omicron sublineages, BA.1+R346K and BA.2, are antigenically similar to the wild-type virus and pose similar risks to the effectiveness of current vaccines. BA.2 also demonstrated resistance to many neutralizing monoclonal antibodies, highlighting the challenges in developing effective therapeutic options.

NATURE (2022)

Add to Collection

Article Dermatology

Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): results from a phase III, randomized, open-label, efficacy-assessor-blinded clinical trial

R. B. Warren et al.

Summary: In the IMMerge study, risankizumab was found to be slightly superior to secukinumab at week 16 and superior at week 52, meeting both primary endpoints, and showing better results on secondary endpoints as well. Overall, at week 52, risankizumab demonstrated superior efficacy and similar safety with less frequent dosing compared to secukinumab.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Add to Collection

Review Dermatology

Common Fundamentals of Psoriasis and Depression

Stefanie HOLSKEN et al.

Summary: Psoriasis and depression are closely related in terms of biological mechanisms, with inflammation playing a key role as a pathophysiological link between the two conditions. Anti-inflammatory therapies may not only treat the clinical manifestations of psoriasis, but also help reduce associated depressive symptoms in patients. However, comparing studies on changes in depressive symptoms in psoriasis is limited by inconsistencies in the depression screening tools used.

ACTA DERMATO-VENEREOLOGICA (2021)

Add to Collection

Article Medicine, General & Internal

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

Einav G. Levin et al.

Summary: A study in Israel revealed that waning immunity after receiving two doses of the BNT162b2 vaccine led to an increase in the incidence of SARS-CoV-2 infection. Levels of spike-binding IgG and neutralizing antibodies decreased more significantly in men, individuals aged 65 or older, and immunosuppressed individuals in a longitudinal study involving nearly 4000 healthcare workers.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Rheumatology

SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases

David Simon et al.

Summary: Immune response against SARS-CoV-2 is delayed and reduced in patients with immune-mediated inflammatory diseases, regardless of treatment.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

Letter Dermatology

Antibody responses to single-dose SARS-CoV-2 vaccination in patients receiving immunomodulators for immune-mediated inflammatory disease

A. Al-Janabi et al.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Psoriasis

Christopher E M Griffiths et al.

LANCET (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Bimekizumab versus Secukinumab in Plaque Psoriasis

Kristian Reich et al.

Summary: In patients with moderate-to-severe psoriasis, treatment with bimekizumab resulted in greater skin clearance than treatment with secukinumab over 16 and 48 weeks but was associated with oral candidiasis. Longer and larger trials are needed to determine comparative effects and risks of interleukin-17 inhibitors in psoriasis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Rheumatology

COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses

Filippo Fagni et al.

Summary: Patients with immune-mediated inflammatory diseases do not have an increased risk of SARS-CoV-2 infection or severe COVID-19, and certain medications like cytokine inhibitors may even lower the risk of severe illness. However, glucocorticoids might worsen COVID-19 outcomes, and the immune response to vaccination in these patients could be somewhat reduced.

LANCET RHEUMATOLOGY (2021)

Add to Collection

Meeting Abstract Oncology

COVID-19 vaccine in participants (ptcpts) with cancer: Subgroup analysis of efficacy/safety from a global phase III randomized trial of the BNT162b2 (tozinameran) mRNA vaccine

S. J. Thomas et al.

ANNALS OF ONCOLOGY (2021)

Add to Collection

Review Rheumatology

Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases

Marcia A. Friedman et al.

Summary: Patients with rheumatic diseases are at increased risk of infectious complications, and disease-modifying antirheumatic drugs can reduce the immunogenicity of common vaccines. Different medications have varying impacts on vaccine immunogenicity, with rituximab having the most substantial effect and Janus kinase and tumour necrosis factor inhibitors decreasing antibody titres. Emerging data suggest that the effect of these medications on the SARS-CoV-2 vaccine immunogenicity is similar to other vaccines, but more research is needed.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

Article Rheumatology

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

Victoria Furer et al.

Summary: Vaccination with mRNA BNT162b2 vaccine showed reduced immunogenicity in patients with AIIRD compared to the general population, with risk factors including older age and treatment with glucocorticoids, rituximab, mycophenolate mofetil (MMF), and abatacept. However, most patients maintained stable disease activity post-vaccination.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

Article Rheumatology

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

Rebecca H. Haberman et al.

Summary: The study found that patients with immune-mediated inflammatory diseases (IMIDs) on methotrexate treatment showed impaired humoral and cellular immune response to COVID-19 mRNA vaccines, while healthy subjects and IMID patients on biologic treatments demonstrated strong antibody responses. These results suggest that different strategies may need to be explored to enhance immunization efficacy for IMID patients on methotrexate treatment.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

Article Hematology

Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma

Irit Avivi et al.

Summary: This single-centre study found that multiple myeloma (MM) patients had a lower seropositive response rate to the BNT162b2 vaccine compared to healthy controls, with older age, hypogammaglobulinaemia, and exposure to multiple anti-myeloma drugs associated with lower response rates. The vaccine was found to be safe and provide high seropositivity in MM patients independent of treatment type.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Add to Collection

Article Dermatology

German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - Part 1: Treatment goals and treatment recommendations

Alexander Nast et al.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2021)

Add to Collection

Article Medicine, General & Internal

Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals

Alexis R. Demonbreun et al.

Summary: A single dose of mRNA vaccine can generate high levels of immune response among individuals previously diagnosed with COVID-19, but two doses are needed for most persons without clinical diagnosis of COVID-19 and seronegative individuals.

ECLINICALMEDICINE (2021)

Add to Collection

Article Immunology

Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany

Tatjana Schwarz et al.

Summary: After receiving the BNT162b2 vaccine, elderly individuals in Germany showed delayed and reduced antibody and T-cell responses compared to healthcare workers, indicating the potential need for additional immunizations for this age group. Nonpharmaceutical interventions for coronavirus disease remain crucial based on this data.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Article Endocrinology & Metabolism

COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges

Rimesh Pal et al.

Summary: This study summarized the evidence on the use of COVID-19 vaccines in patients with diabetes mellitus, highlighting the poor prognosis of COVID-19 in diabetic patients and the importance of prioritizing vaccination. However, there are still unresolved issues regarding COVID-19 vaccination that need to be addressed in future research.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review

Masahiro Kamata et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Rheumatology

Pneumococcal antibody protection in patients with autoimmune inflammatory rheumatic diseases with varying vaccination status

S. L. Rasmussen et al.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2020)

Add to Collection

Article Dermatology

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the UK and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Z. Z. N. Yiu et al.

BRITISH JOURNAL OF DERMATOLOGY (2019)

Add to Collection

Article Public, Environmental & Occupational Health

Vaccinate Patients with Immunodeficiency Instructions for Use of Vaccines recommended by the Standing Vaccination Commission (IV) Vaccination for Patients with Autoimmune Diseases, other chronic inflammatory Diseases and under immunomodulatory Therapy

Norbert Wagner et al.

BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2019)

Add to Collection

Article Rheumatology

Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort study

Silja Buehler et al.

RHEUMATOLOGY (2019)

Add to Collection

Review Dermatology

Safety of biologics in psoriasis

Masahiro Kamata et al.

JOURNAL OF DERMATOLOGY (2018)

Add to Collection

Review Immunology

Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences

Wolf-Henning Boehncke

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Rheumatology

Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjogren's syndrome without disease modifying treatment

Per Nived et al.

BMC RHEUMATOLOGY (2018)

Add to Collection

Review Dermatology

Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression

J. Koo et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)

Add to Collection

Article Rheumatology

Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial

Jin Kyun Park et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

Add to Collection

Article Dermatology

Association of Psoriasis and Metabolic Syndrome in Latin America: A Systematic Review and Meta-Analysis

M. J. M. Rodriguez-Zuniga et al.

ACTAS DERMO-SIFILIOGRAFICAS (2017)

Add to Collection

Article Dermatology

A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis

David Pariser et al.

JOURNAL OF DERMATOLOGICAL TREATMENT (2016)

Add to Collection

Article Dermatology

Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases

C. Phan et al.

ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2016)

Add to Collection

Article Gastroenterology & Hepatology

Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial

Jennifer deBruyn et al.

INFLAMMATORY BOWEL DISEASES (2016)

Add to Collection

Article Dermatology

Association of Psoriasis With the Risk for Type 2 Diabetes Mellitus and Obesity

Ann Sophie Lonnberg et al.

JAMA DERMATOLOGY (2016)

Add to Collection

Article Dermatology

Psoriasis and the Risk of Depression in the US Population National Health and Nutrition Examination Survey 2009-2012

Brandon E. Cohen et al.

JAMA DERMATOLOGY (2016)

Add to Collection

Article Multidisciplinary Sciences

Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials

Jonathan West et al.

PLOS ONE (2016)

Add to Collection

Article Psychology, Clinical

The relationship between psoriasis and depression: A multiple mediation model

Patryk Lakuta et al.

BODY IMAGE (2016)

Add to Collection

Article Dermatology

Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry

P. Gisondi et al.

BRITISH JOURNAL OF DERMATOLOGY (2015)

Add to Collection

Article Gastroenterology & Hepatology

Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients

Patricia Andrade et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)

Add to Collection

Article Dermatology

Patients with psoriasis are insulin resistant

Mette Gyldenlove et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)

Add to Collection

Article Dermatology

Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences

K. Danielsen et al.

BRITISH JOURNAL OF DERMATOLOGY (2015)

Add to Collection

Review Cardiac & Cardiovascular Systems

The Heartbreak of Psoriasis A Review of Cardiovascular Risk in Patients With Psoriasis

Max M. Benson et al.

CARDIOLOGY IN REVIEW (2015)

Add to Collection

Article Dermatology

The association of metabolic syndrome and psoriasis: a population- and hospital-based cross-sectional study

I. M. Miller et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)

Add to Collection

Article Dermatology

Metabolic Syndrome Prevalence in Psoriasis

Aurora Parodi et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2014)

Add to Collection

Review Medicine, General & Internal

Cardiovascular Risk and Psoriasis: Beyond the Traditional Risk Factors

Ann G. Coumbe et al.

AMERICAN JOURNAL OF MEDICINE (2014)

Add to Collection

Article Dermatology

Psoriasis: to treat or to manage?

Ulrich Mrowietz et al.

EXPERIMENTAL DERMATOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease

Yoshie Hagihara et al.

JOURNAL OF CROHNS & COLITIS (2014)

Add to Collection

Article Rheumatology

Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study

Maureen Dubreuil et al.

RHEUMATOLOGY (2014)

Add to Collection

Review Dermatology

Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta-analysis

I. M. Miller et al.

BRITISH JOURNAL OF DERMATOLOGY (2013)

Add to Collection

Article Dermatology

Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors

Iben Marie Miller et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)

Add to Collection

Article Gastroenterology & Hepatology

Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: A prospective study

Gionata Fiorino et al.

INFLAMMATORY BOWEL DISEASES (2012)

Add to Collection

Article Dermatology

Psoriasis and hypertension: a case-control study

S. Armesto et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)

Add to Collection

Article Rheumatology

Protective effect of A/H1N1 vaccination in immune-mediated disease-a prospectively controlled vaccination study

Sabine Adler et al.

RHEUMATOLOGY (2012)

Add to Collection

Article Dermatology

The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity

Wolf-Henning Boehncke et al.

EXPERIMENTAL DERMATOLOGY (2011)

Add to Collection

Article Public, Environmental & Occupational Health

Epidemiology of Psoriasis in Germany - Analysis of Secondary Health Insurance Data

I. Schaefer et al.

GESUNDHEITSWESEN (2011)

Add to Collection

Article Dermatology

Psoriasis and Hypertension: A Case-Control Study

Arnon D. Cohen et al.

ACTA DERMATO-VENEREOLOGICA (2010)

Add to Collection

Article Dermatology

Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the UK

K. Abuabara et al.

BRITISH JOURNAL OF DERMATOLOGY (2010)

Add to Collection

Review Gastroenterology & Hepatology

A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease

W. Miehsler et al.

JOURNAL OF CROHNS & COLITIS (2010)

Add to Collection

Article

Psoriasis and the Risk of Diabetes and Hypertension

Abrar A. Qureshi et al.

ARCHIVES OF DERMATOLOGY (2009)

Add to Collection

Article Dermatology

Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis

D. D. Balci et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)

Add to Collection

Article Dermatology

Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis

J. A. Kaye et al.

BRITISH JOURNAL OF DERMATOLOGY (2008)

Add to Collection

Article Dermatology

National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents

Sean D. Doherty et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)

Add to Collection

Article Medicine, General & Internal

Obesity, waist circumference, weight change, and the risk of psoriasis in women - Nurses' health study II

Arathi R. Setty et al.

ARCHIVES OF INTERNAL MEDICINE (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.